These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 863548)

  • 21. The importance of antibody and macrophages in spontaneous and drug-induced regression of the T1699 mammary adenocarcinoma.
    Haskill JS; Key M; Radov LA; Parthenais E; Korn JH; Fett JW; Yamamura Y; DeLustro F; Vesley J; Gant G
    J Reticuloendothel Soc; 1979 Oct; 26(4):417-25. PubMed ID: 316009
    [No Abstract]   [Full Text] [Related]  

  • 22. Effect of C. parvum on intratumor immunity to the T1699 mammary adenocarcinoma.
    Haskill S; Ritter F; Becker S
    J Immunol; 1980 Jul; 125(1):454-8. PubMed ID: 6247400
    [No Abstract]   [Full Text] [Related]  

  • 23. Analysis of effector cells in human antibody-dependent cellular cytotoxicity with murine monoclonal antibodies.
    Ortaldo JR; Woodhouse C; Morgan AC; Herberman RB; Cheresh DA; Reisfeld R
    J Immunol; 1987 May; 138(10):3566-72. PubMed ID: 2437198
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Emergence of a B lymphocyte population with ADCC effector function in mammary tumor bearing mice.
    Padmanabhan RR; Paul RD; Watson GA; Lopez DM
    J Leukoc Biol; 1988 Jun; 43(6):509-19. PubMed ID: 3259973
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The effect of a single and repeated administration of Corynebacterium parvum on bone marrow macrophage colony production in syngeneic tumor-bearing mice.
    Wolmark N; Fisher B
    Cancer Res; 1974 Nov; 34(11):2869-72. PubMed ID: 4419513
    [No Abstract]   [Full Text] [Related]  

  • 26. In vitro arming and blocking activity of sera from BALB/c mice bearing a spontaneous transplantable adenocarcinoma.
    Landolfo S; Giovarelli M; Forni G
    Eur J Cancer (1965); 1977 Nov; 13(11):1217-23. PubMed ID: 590282
    [No Abstract]   [Full Text] [Related]  

  • 27. Immune response to a mammary adenocarcinoma. V. Sera from tumor-bearing rats contain multiple factors blocking cell-mediated cytotoxicity.
    Huber SA; Lucas ZJ
    J Immunol; 1978 Dec; 121(6):2485-9. PubMed ID: 722081
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Human antibody-dependent cellular cytotoxicity. Isolation and identification of a subpopulation of peripheral blood lymphocytes which kill antibody-coated autologous target cells.
    Brier AM; Chess L; Schlossman SF
    J Clin Invest; 1975 Dec; 56(6):1580-6. PubMed ID: 53242
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Antibody-dependent macrophage-mediated cytolysis in a murine syngeneic tumor system.
    Yamazaki M; Shinoda H; Mizuno D
    Gan; 1976 Oct; 67(5):651-60. PubMed ID: 1017582
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Antibody in the sera of tumor-bearing mice that mediates spleen cell cytotoxicity toward the autologous tumor.
    Blair PB; Lane MA; Mar P
    J Immunol; 1976 Mar; 116(3):606-9. PubMed ID: 176266
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Human bone marrow lymphocytes. Cytotoxic effector cells in the bone marrow of normal individuals.
    Fauci AS; Balow JE; Pratt KR
    J Clin Invest; 1976 Apr; 57(4):826-35. PubMed ID: 947955
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Immune response to inactivated syngeneic mammary adenocarcinoma cells. II. Parameters of immunogenicity in DBA/2 mice.
    DeLustro F; Haskill JS
    J Natl Cancer Inst; 1980 Jan; 64(1):131-7. PubMed ID: 6928038
    [No Abstract]   [Full Text] [Related]  

  • 33. Inhibition of macrophage-mediated cytolysis by lipoproteins from cell-free tumorous ascites.
    Yamazaki M; Shinoda H; Hattori R; Mizuno D
    Gan; 1977 Aug; 68(4):513-6. PubMed ID: 211066
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Immunologic control of the ascites of murine adenocarcinoma 755. I. Protection with syngeneic immune serum or lymphoid cells.
    Haagensen DE; Roloson G; Collins JJ; Wells SA; Bolognesi DP; Hansen HJ
    J Natl Cancer Inst; 1978 Jan; 60(1):131-9. PubMed ID: 628013
    [No Abstract]   [Full Text] [Related]  

  • 35. Immune response to a syngeneic mammary adenocarcinoma. II. In vitro generation of cytotoxic lymphocytes.
    Kuperman O; Fortner GW; Lucas ZJ
    J Immunol; 1975 Nov; 115(5):1277-81. PubMed ID: 51887
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Role of tumor-derived cytokines on the immune system of mice bearing a mammary adenocarcinoma. II. Down-regulation of macrophage-mediated cytotoxicity by tumor-derived granulocyte-macrophage colony-stimulating factor.
    Sotomayor EM; Fu YX; Lopez-Cepero M; Herbert L; Jimenez JJ; Albarracin C; Lopez DM
    J Immunol; 1991 Oct; 147(8):2816-23. PubMed ID: 1918995
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Quantitative effects of nutritional protein and calorie deficiency upon immune responses to tumors in mice.
    Jose DG; Good RA
    Cancer Res; 1973 Apr; 33(4):807-12. PubMed ID: 4633154
    [No Abstract]   [Full Text] [Related]  

  • 38. Inhibition of effector cell functions in natural killer cell activity (NK) and antibody-dependent cellular cytotoxicity (ADCC) in mice by normal and cancer sera.
    Nair PN; Fernandes G; Onoe K; Day NK; Good RA
    Int J Cancer; 1980 May; 25(5):667-77. PubMed ID: 7372374
    [No Abstract]   [Full Text] [Related]  

  • 39. Immunohistologic evidence for the role of antibody and macrophages in regression of the murine T1699 mammary adenocarcinoma.
    Key M; Haskill JS
    Int J Cancer; 1981 Aug; 28(2):225-36. PubMed ID: 7033146
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Experimental solid tumors: the role of macrophages and lymphocytes as effector cells.
    Haskill JS; Radov LA; Yamamura Y; Parthenais E; Korn JH; Ritter FL
    J Reticuloendothel Soc; 1976 Sep; 20(3):233-41. PubMed ID: 1086363
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.